Dilip Kumar Ganguly (born 4 January 1940) is an Indian neurophysiologist, neuropharmacologist,[1] and a former head of the Department of Pharmacology and Experimental Therapeutics and director of the Indian Institute of Chemical Biology.[2][3] Born on 4 January 1940 in Kolkata, in the Indian state of West Bengal, he is known for his researches on Parkinsonism[4] as well as for his efforts in promoting neuropharmacological studies in India,[5] and his researches have been documented by way of several articles in per-reviewed journals.[6][note 1] Besides, he has contributed chapters to books published by others[3] and his work has been cited by any researchers.[7][8][9] He is a founder fellow of the Indian Academy of Neurosciences and has served as its vice president.[10] The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1985.[11]
Seth P, Gajendiran M, Maitra KK, Ross HG, Ganguly DK (1993). "Evidence for D1 dopamine receptor-mediated modulation of the synaptic transmission from motor axon collaterals to Renshaw cells in the rat spinal cord". Neurosci. Lett. 158 (2): 217–20. doi:10.1016/0304-3940(93)90268-p. PMID8233099. S2CID24839288.
Gajendiran M, Seth P, Ganguly DK (1996). "Involvement of the presynaptic dopamine D2 receptor in the depression of spinal reflex by apomorphine". NeuroReport. 7 (2): 513–6. doi:10.1097/00001756-199601310-00033. PMID8730818. S2CID12626993.
Gupta S1, Chaudhuri T, Ganguly DK, Giri AK (2002). "Anticlastogenic effects of black tea (World blend) and its two active polyphenols theaflavins and thearubigins in vivo in Swiss albino mice". Life Sci. 69 (23) (published 2001): 2735–44. doi:10.1002/ptr.1038. PMID12410547. S2CID9167474.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
